Who is sponsoring NCT03254303?

NCT03254303 is sponsored by Leila mansali stambouli.

What drugs are being tested in NCT03254303?

Interventions in NCT03254303: Difficulty of catheterization in group 60 s, Difficulty of catheterization in group 90 s, Difficulty of catheterization in group 120 s.

What condition does NCT03254303 study?

NCT03254303 studies Catheterization.

Is NCT03254303 still recruiting?

NCT03254303 is currently completed. Last updated 18 August 2017.

Last reviewed 2017-08-18 · How we verify

NCT03254303

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Intravenous Cannulation In Children During Sevoflurane Induction

Completed NA Last updated 18 August 2017

What this trial tests

NA trial testing Difficulty of catheterization in group 60 s in Catheterization in 90 participants. Completed in 31 October 2016.

Timeline

1 August 2016

Primary endpoint
31 October 2016

31 October 2016

Quick facts

Lead sponsor	Leila mansali stambouli
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	triple
Primary purpose	other
Enrollment	90
Start date	1 August 2016
Primary completion	31 October 2016
Estimated completion	31 October 2016

Drugs / interventions tested

Difficulty of catheterization in group 60 s
Difficulty of catheterization in group 90 s
Difficulty of catheterization in group 120 s

Conditions studied

Catheterization — all drugs for Catheterization →

Sponsor

Leila mansali stambouli

Who can join

Adults 1 to 12, any sex, with Catheterization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This interventional simple-blind,randomized trial has included 90 children of American Society of Anesthesiologist (ASA) physical status I or II aged between 1 to 12 years of either sex, scheduled for for outpatient minor surgery under general anesthesia. This study examined whether one should make iv attempts during the early induction period (at 60 seconds) or lately (90 or 120 s) and waiting until the child receives additional sevoflurane inhalation anesthesia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Leila mansali stambouli trials

Trials by the same sponsor.

NCT03257800 — Laryngeal Mask Insertion Conditions And Hemodynamic Effects · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03254303 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Leila mansali stambouli
Last refreshed: 18 August 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03254303.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing